|
 |
|
The Inpatient Pain Management Audit (U.S.) 
A syndicated semiannual clinical audit of treatments for moderate to severe pain in acute care hospitals. Information included in the audit includes usage by clinical indication (i.e. specific type of pain), prescribing physician specialty, dosing, duration of therapy, patient demographics and analgesic prescriptions written at discharge.
The IVIG Market Guide (U.S.)
A hospital purchasing audit that provides intravenous immune globulin product market shares (in grams and dollars) ... produced in May and November. Also, a "patient profiling" component that characterizes usage by indication, dosing, ordering physician specialty and patient demographics for recipients of this group of products ... released each November.
The Low Molecular Weight Heparin Inpatient Profile Study (U.S.)
An annual in-depth clinical examination of inpatient Lovenox®, Fragmin®, Innohep® and Arixtra® recipients, including usage by indication (prophylaxis vs. therapy and medical vs. surgical), dosing regimens employed, other anticoagulants given, ordering physician specialty, surgeries performed, and patient demographics. This study is produced in February each year.
The Antipsychotic Monthly Monitor (U.S.)
A monthly syndicated study examining formulary & stocking status, restriction status, and the nature of imposed restrictions for atypical antipsychotic agents. Each study month 250 Pharmacy Directors report from a group of demographically representative hospitals that treat psychiatric patients.
|
